These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16494088)

  • 1. The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study.
    Moraes Wdos S; Poyares DR; Guilleminault C; Ramos LR; Bertolucci PH; Tufik S
    Sleep; 2006 Feb; 29(2):199-205. PubMed ID: 16494088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study.
    Moraes W; Poyares D; Sukys-Claudino L; Guilleminault C; Tufik S
    Chest; 2008 Mar; 133(3):677-83. PubMed ID: 18198262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S; Kameda A; Inagaki T; Horiguchi J
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of donepezil on sleep in elderly, healthy persons: a double-blind placebo-controlled study.
    Schredl M; Hornung O; Regen F; Albrecht N; Danker-Hopfe H; Heuser I
    Pharmacopsychiatry; 2006 Nov; 39(6):205-8. PubMed ID: 17124641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.
    Krishnan KR; Charles HC; Doraiswamy PM; Mintzer J; Weisler R; Yu X; Perdomo C; Ieni JR; Rogers S
    Am J Psychiatry; 2003 Nov; 160(11):2003-11. PubMed ID: 14594748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
    Cooke JR; Loredo JS; Liu L; Marler M; Corey-Bloom J; Fiorentino L; Harrison T; Ancoli-Israel S
    Drugs Aging; 2006; 23(6):503-11. PubMed ID: 16872233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers.
    Nissen C; Nofzinger EA; Feige B; Waldheim B; Radosa MP; Riemann D; Berger M
    Neuropsychopharmacology; 2006 Jun; 31(6):1294-300. PubMed ID: 16192980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study.
    Tune L; Tiseo PJ; Ieni J; Perdomo C; Pratt RD; Votaw JR; Jewart RD; Hoffman JM
    Am J Geriatr Psychiatry; 2003; 11(2):169-77. PubMed ID: 12611746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study.
    Ancoli-Israel S; Amatniek J; Ascher S; Sadik K; Ramaswamy K
    Alzheimer Dis Assoc Disord; 2005; 19(4):240-5. PubMed ID: 16327351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders.
    Buckley AW; Sassower K; Rodriguez AJ; Jennison K; Wingert K; Buckley J; Thurm A; Sato S; Swedo S
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):353-7. PubMed ID: 21851192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil-induced sleep spindle in a patient with dementia with Lewy bodies: a case report.
    Ozaki A; Nishida M; Koyama K; Ishikawa K; Nishikawa T
    Psychogeriatrics; 2012 Dec; 12(4):255-8. PubMed ID: 23279148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
    Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
    Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months.
    Thomas A; Iacono D; Bonanni L; D'Andreamatteo G; Onofrj M
    Clin Neuropharmacol; 2001; 24(1):31-42. PubMed ID: 11290880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of an orally administered cholinergic agonist on REM sleep in major depression.
    Perlis ML; Smith MT; Orff HJ; Andrews PJ; Gillin JC; Giles DE
    Biol Psychiatry; 2002 Mar; 51(6):457-62. PubMed ID: 11922879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons.
    Schredl M; Weber B; Leins ML; Heuser I
    Exp Gerontol; 2001 Feb; 36(2):353-61. PubMed ID: 11226748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia.
    Onofrj M; Thomas A; Iacono D; Luciano AL; Di Iorio A
    Clin Neuropharmacol; 2003; 26(5):239-51. PubMed ID: 14520164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease.
    Mega MS; Masterman DM; O'Connor SM; Barclay TR; Cummings JL
    Arch Neurol; 1999 Nov; 56(11):1388-93. PubMed ID: 10555660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of donepezil on EEG spectral analysis in Alzheimer's disease.
    Balkan S; Yaraş N; Mihçi E; Dora B; Ağar A; Yargiçoğlu P
    Acta Neurol Belg; 2003 Sep; 103(3):164-9. PubMed ID: 14626697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the cholinesterase inhibitor, donepezil, benefit both declarative and non-declarative processes in mild to moderate Alzheimer's disease?
    Winstein CJ; Bentzen KR; Boyd L; Schneider LS
    Curr Alzheimer Res; 2007 Jul; 4(3):273-6. PubMed ID: 17627484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.